You are here

Novartis

Novartis Reports Growth in Q2 2018 Earnings

Market Realist

Wed, 07/18/18 - 12:19 pm

Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes

Endpoints

Wed, 07/18/18 - 09:30 am

Is a Surprise in the Cards for Novartis in Q2 Earnings?

Yahoo/Zacks.com

Mon, 07/16/18 - 09:35 am

Novartis, Michael Cohen contacts were more extensive than previously disclosed

Stat

Fri, 07/13/18 - 12:00 pm

MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too

Fierce Pharma

Fri, 07/13/18 - 11:52 am

Novartis partners with French CDMO to bolster CAR-T supply

Biopharma Dive

Thu, 07/12/18 - 10:40 pm

Pharmas call off price hikes after California law forces new warnings: report

Fierce Pharma

Wed, 07/11/18 - 11:15 pm

Gilead Sciences

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Endpoints

Wed, 07/11/18 - 10:57 pm

Novartis punts a late-stage PI3K drug with a worrying safety profile to one of China’s upstart biotechs

Endpoints

Wed, 07/11/18 - 10:20 am

Mylan launches generic drug-delivery patch for dementia patients

Drug Delivery Business News

Mon, 07/9/18 - 11:26 am

Alzheimer's disease

Parkinson's Disease

3 Best Biotech Acquisitions of 2018 (So Far)

Motley Fool

Thu, 07/5/18 - 09:57 am

Juno Therapeutics

Foundation Medicine

Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert

Fierce Pharma

Wed, 07/4/18 - 10:01 am

Novartis dumps worldwide rights to an Aveo drug, and the little biotech is not happy with them

Endpoints

Tue, 07/3/18 - 11:18 am

Novartis steps in to compete with Mylan’s Epipen

Drug Delivery Business News

Mon, 07/2/18 - 09:27 am

Adamis Pharmaceuticals

Novartis chairman says Alcon worth $20 billion -$30 billion - Finanz und Wirtschaft

Yahoo/Reuters

Sat, 06/30/18 - 12:13 pm

Novartis to spin out Alcon ophthalmic subsidiary

Mass Device

Fri, 06/29/18 - 11:21 am

Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race

Endpoints

Thu, 06/28/18 - 09:45 am

ankylosing spondylitis

Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update

Fierce Pharma

Thu, 06/21/18 - 11:57 am

psoriatic arthritis

5 Experimental New Drugs That Could Be Worth $47 Billion

Motley Fool

Wed, 06/20/18 - 09:26 am

VX-659 + tezacaftor + ivacaftor

Vertex Pharmaceuticals

Novartis touts effectiveness, safety of autoimmune drug copies

Yahoo/Reuters

Fri, 06/15/18 - 09:57 am

autoimmune disease

Pages